Research Extra New Frontiers symposium ENABLE New Frontiers Symposium 2019

ENABLE - New Frontiers symposium 13 - 15 November 2019

Next-generation life scientists: side by side to break new ground.

read more

ENABLE - New Frontiers symposium 13 - 15 November 2019

Every year, RIMLS and RIHS each organize the New Frontiers international symposium across one of the thematic research areas of the Radboudumc with the intention of exploring the newest scientific research and pioneering developments from molecule to man and population.

This year, the RIMLS New Frontiers symposium is co-organized with ENABLE 2019. ENABLE 2019 is a five-day event that takes place from the 11th to the 15th of November 2019. It comprises two days of outreach activities for the general public (November 11-12), a workshop/career day (November 13) and two days of New Frontiers symposium (November 14-15). ENABLE 2019 is organized by and for young researchers and is an inspiring event not to miss!

During the ENABLE 2019 scientific symposium, the opportunities and challenges of the multidisciplinary character of next-generation science will be addressed. Outstanding international speakers in four different topics (Personalized medicine, Advanced imaging, Big data and Fundamental research) will present their latest work. The common thread of ENABLE 2019 will be cutting-edge, innovative and - as the title implies - groundbreaking research, executed side by side by next-generation scientists.

Important note for Radboudumc PhD candidates: participation in the workshop, career day and the scientific symposium can be listed on your TSP.

Save the dates for the 2019 edition

  • Monday 11 & Tuesday 12 November: Outreach activities, open to everyone. 
  • Wednesday 13 November: Career day.
  • Thursday 14 & Friday 15 November: New Frontiers symposium.
  • Registration for career day and scientific symposium opens half March 2019.
  • Tentative program ENABLE 2019. 
  • For PhD candidates & postdocs only.



The registration is closed.

Confirmed speakers

14 November

Personalized medicine
Ayal Hendel
The group of Dr. Ayal Hendel works on the improvement of the CRISPR-Cas9 genome editing technology as a mean of genetic disorder therapy, by increasing the robustness and specificity of the method, to allow its use in clinical settings. His team primarily focuses on correcting mutations in hematopoietic genetic disorders as well as on improving the current immune therapies for fighting cancer through modification of T-cell receptors.

 Hans Clevers
The group of Prof. Hans Clevers uses the technology of adult stem cell-based organoids to recapitulate and study tissue physiology as well as pathological processes. The main aim of his work is to employ patient-derived organoids and genome editing technologies to pave the way for precision medicine. Moreover, Prof. Clevers was the first one to identify stem cells in the adult intestine.

Advanced imaging
Alison Noble
Prof. Alison Noble's main research interest is in biomedical image analysis, by integrating multiple scientific fields from device design to image analysis. Her current research is focused oin the development and application of machine learning tools for improvement of 2D, 3D and video ultrasound analysis, driven by the unmet needs of clinical research in this field.

 Jan Huisken
Prof. Jan Huisken’s main research interest is in the advancement of non-invasive light sheet microscopy for the systematic study of early development in major model organisms, with the ultimate goal of understanding and describing tissue dynamics on the cellular level. His group primarily investigates organogenesis in zebrafish, with a particular focus on the morphogenesis of the cardiovascular system and endoderm.

15 November

Fundamental research

 Antoine Coulon
Dr. Coulon focuses his research on understanding the spatio-temporal organization and dynamics that link the nuclear genome and the gene expression regulation. His group combines state of the art single-molecule imaging, physical/mathematical analysis and modeling techniques. His team’s most recent endeavour has been the development of techniques to visualize transcription in 4D in human cells.

Big Data
 Francesca Ciccarelli
The group of Prof. Francesca Ciccarelli uses systems biology approaches and large datasets to uncover new cancer genes and their genetic networks in the context of tumor onset, progression and evolution. Her studies aim at identifying unique aspects of cancer vulnerability through the analysis of the perturbed cancer networks in order to develop novel therapeutic approaches.

 Emma Lundberg
The group of Dr. Lundberg focuses on spatial proteomics and cell biology using bioimaging and proteomics to understand how protein localization varies among cell types and how it changes in health and disease.  Her laboratory also engages the wider public through Citizen Science projects integrated into globally played online games and data scientists challenges. Dr. Lundberg was also recognized as one of the Top 10 scientists under 40 by GEN.

Accomodations region Nijmegen

For extra discount Hotel Van der Valk Nijmegen - Lent use this link.

Other hotels and more information use this link.